Levetiracetam for the treatment of mild cognitive impairment in Parkinson's disease: a double-blind controlled proof-of-concept trial protocol.

Dissanayaka, Nadeeka; Pourzinal, Dana; Byrne, Gerard J; Yang, Jihyun; McMahon, Katie L; Pontone, Gregory M; O'Sullivan, John D; Adam, Robert; Littleford, Roberta; Chatfield, Mark; Lehn, Alexander; Mari, Zoltan; Bakker, Arnold.

Dissanayaka N; UQ Centre for Clinical Research, The University of Queensland, Herston, QLD, Australia. n.dissanayaka@uq.edu.au.
Pourzinal D; Department of Neurology, Royal Brisbane & Women's Hospital, Herston, QLD, Australia. n.dissanayaka@uq.edu.au.
Byrne GJ; School of Psychology, The University of Queensland, St Lucia, Brisbane, QLD, Australia. n.dissanayaka@uq.edu.au.
Yang J; UQ Centre for Clinical Research, The University of Queensland, Herston, QLD, Australia.
McMahon KL; UQ Centre for Clinical Research, The University of Queensland, Herston, QLD, Australia.
Pontone GM; Mental Health Service, Royal Brisbane & Women's Hospital, Herston, Brisbane, QLD, Australia.
O'Sullivan JD; UQ Centre for Clinical Research, The University of Queensland, Herston, QLD, Australia.
Adam R; School of Clinical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.
Littleford R; Department of Neurology, Johns Hopkins University, Baltimore, USA.
Chatfield M; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, USA.
Lehn A; UQ Centre for Clinical Research, The University of Queensland, Herston, QLD, Australia.
Mari Z; Department of Neurology, Royal Brisbane & Women's Hospital, Herston, QLD, Australia.
Bakker A; UQ Centre for Clinical Research, The University of Queensland, Herston, QLD, Australia.